Special Issue "Immunology and Vaccines against Avian Infectious Diseases"
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 12056
Interests: gut health; necrotic enteritis; clostridium perfringens; avian immunology; mucosal immunity; immunity to viruses; host-microbiome interaction; immunogenicity of vaccine
Interests: host immune responses; virus–host interactions; immunogenicity of vaccines; mucosal immunity; pathogenesis; trained immunity; infectious diseases
Special Issues, Collections and Topics in MDPI journals
Avian immunology is still in the early stages compared to the advancement and knowledge of mammalian immune systems. In addition, infections of microbial pathogens are a problem to avian health and cause an economic challenge primarily to the poultry industry. Furthermore, the effectiveness of vaccination is compromised due to continuing evolution of some of the pathogens and the emergence of new variants. To overcome these hurdles and develop effective control and preventive measures, clear insight into the host immune responses against infectious diseases and vaccines is essential. Current research in infectious diseases using cutting-edge technologies and novel approaches helps understand the mechanism of immune responses of vaccines and microbial pathogens in avian species.
This Special Issue focuses on recent research progress in host immune responses, vaccine-mediated immune responses, and host-microbial interaction in avian species. It will provide an opportunity to share the evolving knowledge on avian immunology, microbiology, and vaccinology in the aspect of infectious diseases to scholars working in this area. Besides, this issue will also consider the developing knowledge on the avian immune system and other immune-related conditions affecting the avian host.
In this Special Issue of Vaccines, original research articles, systematic reviews, perspectives, communications, and case reports are welcome. Research areas include, but are not limited to, the immune responses to viral, bacterial, and parasitic infection, development of vaccines, novel approaches to induce protective innate and adaptive immune responses in the host, microbial-host interaction, and vaccine adjuvants. We encourage scientists to publish their experimental results and conceptual summary in this Special issue.
We look forward to receiving your contributions.
Dr. Alexander Yitbarek
Dr. Jegarubee Bavananthasivam
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- infectious disease
- viral infection
- bacterial infection
- parasitic infection
- host-pathogen interaction
- vaccine adjuvant
- innate responses
- adaptive immune response